Patients who received IV-PCA following a spine surgery or an upper limb surgery
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients who received IV-PCA following a spine surgery or an upper limb surgery between January 2012 and September 2018 were eligible for this study.
Exclusion criteria
Exclusion criteria: Patients who did not receive IV-PCA following a spine surgery or an upper limb surgery between January 2012 and September 2018 were not eligible for this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Postoperative nausea and vomiting observed within 48 hours after the orthopedic surgical procedure | — |
Secondary
| Measure | Time frame |
|---|---|
| Age, gender, BMI, alcohol drinking status, smoking status, surgical duration, anesthesia duration, intraoperative fentanyl and remifentanil dose, and postoperative fentanyl concentration were analysed between PONV patients and non-PONV patients. | — |
Countries
Japan
Contacts
Kumamoto Central Hospital Department of anesthesiology